These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34907483)

  • 21. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor.
    Tang H; Chen X; Rui M; Sun W; Chen J; Peng J; Xu Y
    Mol Pharm; 2014 Oct; 11(10):3242-50. PubMed ID: 25181533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of liposomal formulations for cell targeting.
    Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2015 Dec; 136():514-26. PubMed ID: 26454541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomes, a promising strategy for clinical application of platinum derivatives.
    Zalba S; Garrido MJ
    Expert Opin Drug Deliv; 2013 Jun; 10(6):829-44. PubMed ID: 23470129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The benefits and challenges associated with the use of drug delivery systems in cancer therapy.
    Cukierman E; Khan DR
    Biochem Pharmacol; 2010 Sep; 80(5):762-70. PubMed ID: 20417189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.
    Nikolova MP; Kumar EM; Chavali MS
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposome technologies towards colorectal cancer therapeutics.
    Sang R; Stratton B; Engel A; Deng W
    Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomes: An Emerging Approach for the Treatment of Cancer.
    Mishra K; Jain AK
    Curr Pharm Des; 2021; 27(20):2398-2414. PubMed ID: 33823772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of targeting thermosensitive liposomes for tumor treatment].
    Chen J
    Yao Xue Xue Bao; 2011 May; 46(5):502-6. PubMed ID: 21800535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents.
    Jha S; Sharma PK; Malviya R
    Recent Pat Drug Deliv Formul; 2016; 10(3):177-183. PubMed ID: 27712569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Composition design and medical application of liposomes.
    Li M; Du C; Guo N; Teng Y; Meng X; Sun H; Li S; Yu P; Galons H
    Eur J Med Chem; 2019 Feb; 164():640-653. PubMed ID: 30640028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review.
    Abbasi H; Rahbar N; Kouchak M; Khalil Dezfuli P; Handali S
    J Liposome Res; 2022 Jun; 32(2):195-210. PubMed ID: 33729077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal Delivery Systems: Design Optimization and Current Applications.
    Abu Lila AS; Ishida T
    Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
    Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
    J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.
    Goins B; Phillips WT; Bao A
    Expert Opin Drug Deliv; 2016 Jun; 13(6):873-89. PubMed ID: 26981891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of liposomes as drug delivery system for therapeutic applications.
    Guimarães D; Cavaco-Paulo A; Nogueira E
    Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomes in the Targeted Gene Therapy of Cancer: A Critical Review.
    Akkewar A; Mahajan N; Kharwade R; Gangane P
    Curr Drug Deliv; 2023; 20(4):350-370. PubMed ID: 35593362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing of 'intelligent' liposomes for efficient delivery of drugs.
    Voinea M; Simionescu M
    J Cell Mol Med; 2002; 6(4):465-74. PubMed ID: 12611636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.